Table I.
Patients' information used in current research in the TCGA and GSE21501 cohorts.
| Group | Description | TCGA | GSE21501 |
|---|---|---|---|
| Male | – | 94 | − |
| Female | – | 78 | − |
| Stage I | – | 21 | − |
| Stage II | – | 145 | − |
| Stage III | – | 3 | − |
| Stage IV | – | 5 | − |
| T1 | Confined to the pancreas, ≤2 cm in diameter | − | 2 |
| T2 | Confined to the pancreas, 2 cm < diameter ≤4 cm | − | 16 |
| T3 | Confined to the pancreas, >4 cm in diameter | − | 79 |
| T4 | Extends outside the pancreas and into nearby major blood vessels | − | 1 |
| N0 | No spread to nearby lymph nodes | − | 28 |
| N1 | Spreads to no more than 3 nearby lymph nodes | − | 73 |